The Triage BNP Test is a rapid, point-of-care fluorescence immunoassay to be used with the Triage Meters for the quantitative measurement of B-type natriuretic peptide (BNP) in EDTA anticoagulated whole blood or plasma specimens. The test is intended to be used as an aid in the diagnosis and assessment of severity of congestive heart failure (also referred to as heart failure). The test also is used for the risk stratification of patients with acute coronary syndromes and for the risk stratification of patients with heart failure.
The only CLIA-waived blood test measuring B-type natriuretic peptide (BNP). Cardiac hormone produced by the heart ventricles in response to ventricular volume expansion and pressure overload. CLIA waived for use with whole-blood samples.